[Anti-inflammatory effect of iprazid and DG-2].
D000315:Adrenalectomy; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D002351:Carrageenan / Q000037:antagonists & inhibitors*; D003864:Depression, Chemical; D004487:Edema / Q000139:chemically induced / Q000517:prevention & control*; D005557:Formaldehyde / Q000037:antagonists & inhibitors*; D007490:Iproniazid / Q000494:pharmacology* / Q000627:therapeutic use; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D051381:Rats; D012702:Serotonin Antagonists; D013268:Stimulation, Chemical; D014361:Trypsin Inhibitors / Q000494:pharmacology
D000893:Anti-Inflammatory Agents; D008996:Monoamine Oxidase Inhibitors; D012702:Serotonin Antagonists; D014361:Trypsin Inhibitors; D005557:Formaldehyde; D002351:Carrageenan; D007490:Iproniazid
Protivovospalitel'noe deĭstvie iprazida i DG-2.